This Solicitation opportunity from Department Of Defense was posted on June 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

BUPIVACAINE AND EPI

Closed

SPE2DP-26-T-3654Federal

Submission Closed06/09/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

PLASMA-LYTE A INJECThe contract involves the procurement of PLASMA-LYTE A INJEC, identified by NSN 6505-01-708-9039, with a total quantity of three units requested under purchase request number 7017120906. The solicitation, designated SPE2DP-26-T-3802, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. The response deadline for the solicitation is June 22, 2026, indicating a brief window for submissions. This contract is categorized as a solicitation with no specified type of set-aside or applicable NAICS code, and the performance location details are not provided. The contracting agency is a federal entity focusing on defense logistics, ensuring the procurement supports government operations. Relevant contract information and updates are accessible via the Defense Logistics Agency's procurement platform.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by the National Stock Number 6505-01-718-3484. The request involves a quantity of five units under purchase request number 7013890090. This solicitation, numbered SPE2DP-26-T-3808, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The procurement is managed by the Defense Logistics Agency, a federal organization within the Department of Defense, and is intended for performance within the United States, although specific locations are not specified. This contract solicitation falls under federal acquisition and does not indicate any set-aside type or NAICS code, implying it may be open to all qualified bidders. The relevant information is accessible through the Defense Logistics Agency’s online portal, where potential vendors can review and respond to the request. Points of contact are not provided in the available data, indicating that interested parties may need to use the online platform for further inquiries.

Defense Logistics Agency

POSTED

DEADLINE

REHYDRATION SALTS FThe contract pertains to the procurement of rehydration salts, specifically identified by the NSN/Part Number 6505-01-731-2277, with a total quantity of 2 units requested under purchase request number 7015714540. The solicitation, titled "REHYRATION SALTS F," was issued by the Defense Logistics Agency, a component of the Department of Defense, on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. This federal solicitation lacks set-aside designations and NAICS code details, indicating it was open to all qualified bidders. The place of performance details were unspecified, suggesting flexibility or further clarification in subsequent communications. The contract focuses on meeting the agency's need for these medical supplies, likely for use in rehydration treatment scenarios, aligning with the Department of Defense's logistical and operational requirements.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by NSN/Part Number 6505-01-718-3478, with a purchase request quantity of five units. This solicitation, numbered SPE2DP-26-T-3803, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The contracting agency responsible for this procurement is the Defense Logistics Agency under the Department of Defense. This contract is a federal solicitation with no set-aside type indicated, and no specific NAICS code was assigned. While the precise location for the place of performance and the office address details are not provided, the procurement is handled within the United States. The contract is publicly available for review on the Defense Logistics Agency’s electronic bidding system, allowing eligible vendors to respond within the designated timeframe.

Defense Logistics Agency

POSTED

DEADLINE

PSYLLIUM HYDROPHILIThe contract pertains to the procurement of Psyllium Hydrophili, identified by the NSN/Part Number 6505-01-719-3181, with a purchase request for a quantity of three units. The solicitation, numbered SPE2DP-26-T-3801, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. It is a federal solicitation, with a response deadline set for June 22, 2026. The contract does not specify any set-aside type or NAICS code, and the exact location details for the office or place of performance are not provided. This solicitation is intended to acquire the specified product through a formal bidding process managed by a federal defense agency. Interested parties are able to access the solicitation and submit their responses through the Defense Logistics Agency’s bidding platform. The contract focuses on ensuring timely procurement within the established deadlines and under federal regulations relevant to government acquisitions.

Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

This contract pertains to the procurement of bupivacaine and epinephrine, identified by the NSN/Part Number 6505-01-189-3973, with a quantity of five units requested under purchase request 7017017002. The solicitation number is SPE2DP-26-T-3654, issued by the Defense Logistics Agency within the Department of Defense. The solicitation was posted on June 3, 2026, with a response deadline set for June 9, 2026, indicating a brief window for potential suppliers to submit their offers. The contract is a federal solicitation without any specified set-aside type or NAICS code, and it is intended for performance in an unspecified location within the United States. No specific office or point of contact details are provided. The procurement focuses on acquiring the medical product combination of bupivacaine and epinephrine, likely for medical or defense-related applications, aligning with the agency’s mission to support defense logistics requirements.

General Info

Procurement of five units bupivacaine and epinephrine, solicitation SPE2DP-26-T-3654, June 9 deadline.

Agency

Department Of Defense → Defense Logistics Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers View NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJun 3

Solicitation

Response DeadlineJun 9

Deadline has passed

Submission Closed

06/09/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUS

Organization / Agency

Department Of Defense → Defense Logistics Agency

Office AddressUS

ContactsNo contact information available

Full Description

BUPIVACAINE AND EPI NSN/Part Number: 6505-01-189-3973 Purchase Request: 7017017002QTY: 5